Both NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are direct precursors to NAD+ (nicotinamide adenine dinucleotide), the coenzyme responsible for cellular energy production, DNA repair, and sirtuin activation. They differ in molecular size, the enzymatic pathway each takes to become NAD+, and the volume of human clinical evidence behind each. NMN enters the NAD+ synthesis pathway one step closer to the final molecule and has accumulated a stronger body of recent human trial data.
What Is NMN?
NMN is a nucleotide derived from ribose and nicotinamide. It is a naturally occurring compound found in small amounts in foods like edamame, broccoli, avocado, and beef. In the body, NMN is the immediate precursor to NAD+. The enzyme NMNAT (nicotinamide mononucleotide adenylyltransferase) converts NMN directly into NAD+ inside the cell. This is the final step in the primary NAD+ biosynthesis pathway.
NMN has a molecular weight of 334.22 g/mol. Research published since 2020 has demonstrated that oral and sublingual NMN supplementation raises blood NAD+ levels in humans within days of starting supplementation.
What Is NR (Nicotinamide Riboside)?
NR is a form of vitamin B3 and a precursor to NMN. It is smaller than NMN, with a molecular weight of 255.25 g/mol. NR enters cells and is converted to NMN by the enzyme NRK (nicotinamide riboside kinase), then NMN is converted to NAD+ by NMNAT. This means NR requires one additional enzymatic step compared to NMN before becoming NAD+.
NR has been on the supplement market longer than NMN and has more published human studies overall, though many of those studies are older and used different outcome measures than current NMN research.
How Do NMN and NR Differ in the Body?
The core metabolic difference is position in the pathway. NR must be phosphorylated to NMN before the final conversion to NAD+. NMN skips that step entirely.
Whether this positional advantage translates to meaningfully higher NAD+ levels in humans is an active area of research. Two points are established:
- Both compounds reliably raise blood NAD+ levels in human trials
- Neither has been directly compared head-to-head in a rigorous randomized controlled trial
NMN has a larger molecular weight than NR, which led to early debate about whether NMN could cross cell membranes directly. A 2019 study by Grozio et al. identified a specific NMN transporter protein (Slc12a8) in the small intestine, confirming NMN can be taken up directly by intestinal cells without first being converted to NR outside the cell.
Sublingual NMN, absorbed through the oral mucosa, bypasses this intestinal transport question entirely by entering the bloodstream directly, avoiding the digestive tract and first-pass liver metabolism.
What Does Research Show About NMN vs NR?
For NMN, key human trials include:
- Yoshino et al. 2021 (Cell Metabolism): 250 mg NMN daily improved muscle insulin sensitivity in postmenopausal women with prediabetes
- Igarashi et al. 2022 (NPJ Aging): 250 mg NMN daily raised blood NAD+ and improved physical performance in older adults
- Yi et al. 2021 (Cell Reports Medicine): NMN improved aerobic capacity and O2 utilization in amateur runners over 6 weeks
For NR, key human trials include:
- Elhassan et al. 2019 (Cell Reports): NR raised blood NAD+ and activated sirtuins in skeletal muscle in older adults
- Dollerup et al. 2018 (Nature Communications): 2,000 mg NR daily raised blood NAD+ but showed no effect on insulin sensitivity in obese men over 12 weeks
- Martens et al. 2018 (Nature Communications): NR reduced blood pressure and arterial stiffness in middle-aged and older adults with elevated systolic pressure
Which Has More Clinical Evidence?
NR has a longer track record as a supplement and a larger total number of published human studies, largely because it entered the market earlier. However, NMN's human trial results are more consistent in showing functional benefits, not just NAD+ elevation. The 2021 and 2022 NMN trials demonstrated outcomes including improved insulin sensitivity, better physical performance, and enhanced aerobic capacity, outcomes that go beyond simply raising a biomarker.
NR trials show reliable NAD+ elevation but mixed results on functional endpoints. The Dollerup 2018 trial, despite using a high dose of 2,000 mg NR daily, found no improvement in insulin sensitivity in obese participants. This contrast with the NMN insulin sensitivity data is notable, though the populations studied differ.
NMN vs NR: A Direct Comparison
| Category | NMN | NR |
|---|---|---|
| Steps to NAD+ | 1 (direct conversion by NMNAT) | 2 (NRK converts to NMN, then NMNAT converts to NAD+) |
| Molecular weight | 334.22 g/mol | 255.25 g/mol |
| Raises blood NAD+ | Yes, confirmed in multiple human trials | Yes, confirmed in multiple human trials |
| Functional human trial outcomes | Improved insulin sensitivity, physical performance, aerobic capacity | Reduced blood pressure; mixed results on metabolic endpoints |
| Total published human studies | Growing rapidly since 2020 | Larger body of older research |
| Sublingual delivery available | Yes | Rarely |
| Typical effective dose in trials | 250 to 500 mg/day | 250 to 2,000 mg/day |
Which Should You Take?
Both compounds are legitimate NAD+ precursors with a demonstrated safety record in humans. The decision comes down to three factors: pathway efficiency, clinical evidence for functional outcomes, and delivery method.
NMN is one step closer to NAD+ in the biosynthesis pathway. The recent human trials for NMN show consistent functional improvements, not just elevated biomarkers. And with sublingual delivery, NMN reaches the bloodstream faster and more completely than capsule forms of either compound.
If the goal is to raise NAD+ levels and support measurable outcomes like metabolic health and physical performance, the current human trial data favors NMN, particularly in sublingual form.
Purpose NMN delivers nicotinamide mononucleotide via a sublingual pouch that absorbs directly through the oral mucosa, bypassing the digestive tract entirely. Founded by 82nd Airborne veteran Dave Burke, Purpose is built on the belief that the science of cellular health should be accessible and straightforward. Learn More About Purpose NMN